Insider trades
Aaron Kantoff, Director of Avalo Therapeutics AVTX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/02.
Aaron Kantoff
Director
- Company
- Avalo Therapeutics AVTX
- First filing
- 23/10/23
- Trades
- 22 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 06/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 23/10/24 | 23/10/26 | 7,500 sh | $11.86 | $88,950 | +19.8% |